APGE — Apogee Therapeutics Balance Sheet
0.000.00%
Last trade - 00:00- $2.78bn
- $1.96bn
- 25
- 32
- 91
- 47
Annual balance sheet for Apogee Therapeutics, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2022 December 31st | 2023 December 31st | |
|---|---|---|
| Period Length: | — | — |
| Source: | PROSPECTUS | 10-K |
| Standards: | USG | USG |
| Status: | Final | Final |
| Cash | ||
| Cash and Equivalents | ||
| Short Term Investments | ||
| Cash and Short Term Investments | 152 | 395 |
| Prepaid Expenses | ||
| Total Other Current Assets | ||
| Total Current Assets | 152 | 398 |
| Net Property, Plant And Equipment | — | 2.59 |
| Other Long Term Assets | ||
| Total Assets | 152 | 401 |
| Accounts Payable | ||
| Accrued Expenses | ||
| Notes Payable / Short Term Debt | ||
| Total Current Liabilities | 9.98 | 20.6 |
| Total Long Term Debt | ||
| Total Debt | ||
| Total Other Liabilities | ||
| Total Liabilities | 9.98 | 21.5 |
| Redeemable Preferred Stock | ||
| Non Redeemable Preferred Stock | ||
| Common Stock | ||
| Additional Paid In Capital | ||
| Retained Earnings (Accumulated Deficit) | ||
| Other Equity | ||
| Total Equity | 142 | 380 |
| Total Liabilities & Shareholders' Equity | 152 | 401 |
| Total Common Shares Outstanding |